Encore Global Management’s Biogen BIIB Stock Holding History

Encore Global Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$108K	Hold	500	–	–	0.11%	51
2026 Q1	$91.7K	Buy	+500	New	+$92.1K	0.06%	69

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Encore Global Management's BIIB Position: Q2 2026 in Review

Encore Global Management held its Biogen (BIIB) position steady in Q2 2026 at 500 shares worth $108K. The position accounts for 0.11% of the portfolio, ranked #51.

Encore Global Management first reported a position in BIIB in Q1 2026 and has held it in 2 quarters since. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Encore Global Management held 500 shares of Biogen worth $108K as of Q2 2026.
Encore Global Management left its Biogen share count unchanged in Q2 2026.
Biogen made up 0.11% of Encore Global Management's portfolio in Q2 2026, its #51 holding.
Encore Global Management first reported a position in Biogen in Q1 2026 and has held it in 2 quarters since.
1,041 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Encore Global Management's 13F filing for Q2 2026, filed 11 Aug 2026.